Foresite Capital Management II as of Dec. 31, 2018
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 10 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aimmune Therapeutics | 37.6 | $71M | 3.0M | 23.92 | |
| Aerie Pharmaceuticals | 32.0 | $60M | 1.7M | 36.10 | |
| Alder Biopharmaceuticals | 8.6 | $16M | 1.6M | 10.25 | |
| Insmed (INSM) | 6.7 | $13M | 968k | 13.12 | |
| Epizyme | 5.1 | $9.6M | 1.6M | 6.16 | |
| Acceleron Pharma | 4.8 | $9.1M | 210k | 43.55 | |
| Adaptimmune Therapeutics (ADAP) | 2.1 | $4.0M | 700k | 5.75 | |
| BioDelivery Sciences International | 1.6 | $2.9M | 797k | 3.70 | |
| Twist Bioscience Corp (TWST) | 0.9 | $1.7M | 73k | 23.09 | |
| Natera (NTRA) | 0.5 | $964k | 69k | 13.96 |
